XML 109 R70.htm IDEA: XBRL DOCUMENT v3.20.2
Earnings per Share (Details) - USD ($)
shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Numerator:        
Net income attributable to Biogen Inc. $ 701.5 $ 1,545.9 $ 3,642.7 $ 4,448.8
Weighted-average shares used in calculating:        
Weighted average number of common shares outstanding 156.9 184.0 163.4 190.3
Effect of dilutive securities:        
Dilutive potential common shares 0.3 0.2 0.3 0.2
Shares used in calculating diluted earnings per share 157.2 184.2 163.7 190.5
Time-vested restricted stock units        
Effect of dilutive securities:        
Stock units 0.1 0.1 0.1 0.1
Market stock units        
Effect of dilutive securities:        
Stock units 0.1 0.1 0.1 0.1
Performance stock units settled in stock        
Effect of dilutive securities:        
Stock units 0.1 0.0 0.1 0.0